UBS Group’s Incannex Healthcare IXHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$121K Buy
40,369
+35,544
+737% +$258K ﹤0.01% 6910
2025
Q4
$51.8K Sell
4,825
-816
-14% -$9.42K ﹤0.01% 7198
2025
Q3
$78.5K Buy
5,641
+3,265
+137% +$53K ﹤0.01% 7271
2025
Q2
$15.4K Buy
2,376
+2,146
+933% +$21.2K ﹤0.01% 8613
2025
Q1
$4.66K Sell
230
-79
-26% -$3.43K ﹤0.01% 9080
2024
Q4
$19.6K Buy
309
+211
+215% +$12.7K ﹤0.01% 7884
2024
Q3
$5.84K Sell
98
-102
-51% -$6.3K ﹤0.01% 8021
2024
Q2
$17.6K Buy
200
+103
+106% +$8.89K ﹤0.01% 7384
2024
Q1
$10.5K Buy
+97
New +$11.7K ﹤0.01% 7227
2023
Q4
Sell
-1
Closed -$90 9592
2023
Q3
$90 Buy
+1
New +$192 ﹤0.01% 8910
2023
Q1
Sell
-25
Closed -$8.43K 9967
2022
Q4
$8.43K Sell
25
-3
-11% -$1.37K ﹤0.01% 8772
2022
Q3
$15K Buy
28
+19
+211% +$9.95K ﹤0.01% 7804
2022
Q2
$4K Sell
9
-14
-61% -$11.4K ﹤0.01% 9080
2022
Q1
$25K Buy
+23
New +$38K ﹤0.01% 7192

Other funds holding IXHL

UBS Group's IXHL Position: Q1 2026 in Review

UBS Group increased its Incannex Healthcare (IXHL) stake by 737% in Q1 2026, buying an estimated $258K and bringing the position to 40,369 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #6910.

UBS Group first reported a position in IXHL in Q1 2022 and has held it in 14 quarters since. 21 funds tracked by Wall St. Rank hold IXHL as of Q1 2026.

  • UBS Group held 40,369 shares of Incannex Healthcare worth $121K as of Q1 2026.
  • UBS Group bought 35,544 Incannex Healthcare shares in Q1 2026, an estimated $258K.
  • Incannex Healthcare made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6910 holding.
  • UBS Group first reported a position in Incannex Healthcare in Q1 2022 and has held it in 14 quarters since.
  • 21 funds tracked by Wall St. Rank held Incannex Healthcare as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.